DalsnaFinance

Emergent Biosolutions Inc $EBS

Health Care

Russell 2000

Create a scorecard

$6.21

-0.02 (-0.32%)

As of Sep 5, 2026, 5:22 PM EDT

Price history

Loading chart…

Emergent Biosolutions Inc (EBS) is trading down at $6.21 (-0.32%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

About Emergent Biosolutions Inc

Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.

Source: Wikipedia — Emergent BioSolutions

Recent News (7)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS PR Newswire · 03 Sep 2026 NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advised…
Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes GlobeNewswire · 03 Sep 2026 GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has completed the repurchase of $75 million aggregate principal amount of its 3.8…
Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) GlobeNewswire · 01 Sep 2026 GAITHERSBURG, Md., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification valued at approximately $24 million from the Biomedical Advanced …
Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray GlobeNewswire · 31 Aug 2026 WINNIPEG, Manitoba, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has been awarded a standing offer by the Government of Canada, through a competit…
Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day GlobeNewswire · 31 Aug 2026 GAITHERSBURG, Md., Aug. 31, 2026 (GLOBE NEWSWIRE) -- In recognition of International Overdose Awareness Day (IOAD), Emergent BioSolutions (NYSE: EBS) is reaffirming its commitment to expanding aware…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS PR Newswire · 27 Aug 2026 NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advised…
H.C. Wainwright cuts Emergent BioSolutions stock price target on revenue outlook Investing.com · 10 Aug 2026 H.C. Wainwright cuts Emergent BioSolutions stock price target on revenue outlook

More Health Care stocks

AZN AstraZeneca
ILMN Illumina
A Agilent Technologies
ABBV AbbVie
ABT Abbott Laboratories
ALGN Align Technology
AMGN Amgen
BAX Baxter International

Browse all companies →